425: AIR Holdings CEO: SPAC Merger, Quantum Vapes, and Growth

AIR Holdings CEO Stuart Brazier provided updates on the company's SPAC merger with Cantor Equity Partners III, Inc., new product launches, and strong financial performance.

Summary

• AIR Limited is progressing towards a SPAC merger with Cantor Equity Partners III, Inc. (CAEP), with a listing forecast for the first half of 2026 under the ticker AIIR.
• The company recently launched 'Crown Switch,' a new vape product in Germany utilizing 'quantum chip' technology that heats liquid without a coil or wick, reducing the risk of inhaling heavy metals and making inhalation more efficient.
• Crown Switch is currently available online in Germany via the ShishaWorld platform, with plans for rollout to other European markets and then the US, pending regulatory approvals like FDA.
• AIR's core business, primarily hookah molasses, delivered approximately $375 million in net revenue in 2024, with a 60% gross margin and $150 million in adjusted EBITDA.
• The company reported a net operating cash flow of $149 million, highlighting its strong cash generation.
• AIR is the global leader in hookah molasses, holding over 60% market share in the US.
• The SPAC deal values AIR at an enterprise value of $1.75 billion, with an implied equity value of $1.456 billion and an EV/EBITDA multiple of approximately 11x.
• AIR is not seeking to raise capital through a PIPE in this transaction; cash inflow will depend on SPAC investor redemptions.
• Other innovations include 'Ooka,' a Nespresso-like hookah device available in the US, and 'Vant,' a functional inhalable product (e.g., inhaled caffeine, valerian root) being test-marketed in Spain and the US, leveraging the same quantum chip technology with exclusivity in its category.
• The company is also developing products for the nicotine pouch market, which has a global TAM of $30 billion and is growing rapidly, with future plans for non-nicotine functional pouches.
• The initial F-4 filing with the SEC is expected within the next 10 days from December 4, 2025, with SEC review and subsequent revisions anticipated over several months.

Sentiment

Score: 9

Explanation: The filing conveys a highly positive outlook, driven by strong financial performance, market leadership, significant innovation in high-growth adjacent markets, and a favorable SPAC valuation. Management's confidence in future growth and shareholder returns is evident.

Positives

• AIR is profitable and cash flow positive, generating $149 million in net operating cash flow in 2024, which is uncommon for a company going public via SPAC.
• The core hookah molasses business boasts strong financials with $375 million in net revenue, a 60% gross margin, and $150 million in adjusted EBITDA.
• The company holds a dominant market position as the global leader in hookah molasses, with over 60% market share in the US.
• Significant innovation is underway with new products like the 'Crown Switch' vape, 'Ooka' device, and 'Vant' functional inhalables, targeting large and growing adjacent markets.
• The 'quantum chip' technology in new vape products offers a potentially healthier alternative by eliminating combustion and reducing the risk of inhaling heavy metals.
• The total addressable market (TAM) for vapes is $30 billion globally, growing at 4-5% annually in Western markets, and the nicotine pouch market is also $30 billion and growing even faster.
• The company has a healthy balance sheet with over $100 million cash on hand by year-end and leverage below 2.5, providing flexibility for future growth, M&A, or shareholder returns.
• Collaborations with high-profile figures like Snoop Dogg and brands like Cookies enhance market visibility and excitement.

Risks

• The SPAC merger may not be completed in a timely manner or at all, which could adversely affect the price of CAEP's securities.
• Failure to satisfy the conditions to the consummation of the Transactions, including the approval of CAEP's shareholders, could prevent the merger from closing.
• The level of redemptions by CAEP's public shareholders could reduce the public float and liquidity of the trading market for the shares.
• There is a risk that Pubco may fail to obtain or maintain the listing of its securities on any securities exchange after the closing of the Transactions.
• Costs related to the Transactions and becoming a public company could impact financial performance.
• Changes in business, market, financial, political, and regulatory conditions could affect future operations.
• Increased competition in the industries in which Pubco will operate poses a challenge to market share and profitability.
• Difficulties in managing growth and expanding operations, particularly with new product categories and international rollouts, could arise.
• Challenges in implementing Pubco's business plan, including operational hurdles, significant competition, and evolving regulations, are present.
• Regulatory approval processes, such as FDA clearance for US market entry of new vape products, can be time-consuming and unpredictable.

Future Outlook

The company anticipates listing on a public exchange in the first half of 2026 following the SPAC merger. It plans to expand its new product lines, including the Crown Switch vape, Ooka device, Vant functional inhalables, and nicotine pouches, into new European and US markets. Management also indicated potential for bolt-on M&A, share buybacks, or dividends depending on future cash flows and market conditions.

Management Comments

• "We're just progressing towards that listing that we're forecasting will be in the first half of 2026."
• "Our core business delivered an NTO or a revenue, net revenue of close to three hundred seventy five million dollars. The margins in the core business are very attractive. So that's a 60 percent margin. And that drove an adjusted EBITDA of around one hundred and fifty million U.S. dollars."
• "Importantly, at a consolidated view, our net operating cash flow was one hundred and forty nine million dollars. So it's not just a company that, you know, sells a lot and generates a lot of profit. But most importantly, it generates a lot of cash as well."
• "We're the global leader in hookah molasses. You know, we, as an example, in the US, we've got over a 60 percent share of the market."
• "We have chosen to invest some of that cash into innovation, into building research, development teams, into building capabilities in the organisation to come up with new innovations and actually take those into adjacent nicotine spaces."
• "As a town, the total vape category globally is larger [than hookah molasses]."
• "It's such a fun space, right? I mean, you know, Rhett, you talk about you went into the shop and the guy knew about it. It really is. You know, people do love this category. They get very, very passionate about it because it takes so long to put it together. You know, they invite their friends over and say, well, let's enjoy a hookah together. And it is that, you know, it's that social experience that really defines the category."
• "With hookah, there isn't combustion. So it's not smoke. You're actually heating it rather than combusting it. So, you know, the molasses vaporises and turns into this cloud."
• "We're not looking to raise capital. So we're not raising a PIPE or anything like that. So we will not know how much cash comes into the business until we actually list."
• "Having a healthy balance sheet allows you to accelerate plans where you see the opportunity to do so. And it can also give us the opportunity to do some bolt-on the M&A if we think it's accretive and makes sense. And otherwise, there's always the option for share buybacks if we do or, you know, or dividends."

Industry Context

The company operates within the evolving nicotine and functional inhalables market, which is seeing a significant shift from traditional tobacco products towards 'reduced risk' alternatives like vapes and nicotine pouches. The global vape market is valued at $30 billion and growing, while the nicotine pouch market is also $30 billion and expanding even faster. The company's focus on innovation, particularly with 'quantum chip' technology, positions it to capitalize on consumer demand for safer and more efficient delivery systems. Its core hookah business taps into a social and lifestyle phenomenon, distinct from traditional smoking.

Comparison to Industry Standards

• The company's profitability and cash flow positive status ($149 million net operating cash flow) are noted as 'impressive for a SPAC' and 'you just don't see that,' indicating performance significantly better than many SPAC targets.
• The implied enterprise value to EBITDA multiple of approximately 11x is described as 'crazy to see that kind of valuation on a SPAC,' suggesting a premium valuation compared to typical SPACs, likely due to its strong fundamentals.
• Unlike many SPACs that 'violently drop to like three or four dollars within a day,' the company's strong financial position and valuation suggest a potentially more stable post-merger trading performance.

Stakeholder Impact

• Shareholders of CAEP and AIR will be impacted by the successful completion of the SPAC merger and the subsequent listing of Pubco, with potential for value appreciation given the strong underlying financials.
• Customers will benefit from new, innovative products like the Crown Switch vape, Ooka, and Vant, offering potentially safer and more convenient alternatives in the inhalation space.
• Employees may see increased opportunities due to company growth, expansion into new markets, and continued investment in research and development.
• Regulatory bodies, particularly the SEC and FDA, will be involved in the review and approval processes for the merger and new product introductions, ensuring compliance and consumer safety.
• Suppliers and partners, such as Green Tank Technologies, will continue to collaborate on new product development and distribution.

Next Steps

• Submit the initial F-4 filing with the SEC within the next 10 days (from December 4, 2025).
• Engage in the SEC review process, which involves multiple rounds of feedback and revisions to the F-4 filing.
• Time the final F-4 submission with the latest financials to avoid them going stale (after 135 days).
• Obtain approval from CAEP's shareholders for the business combination.
• Complete the SPAC merger and list on a public exchange under the ticker AIIR, forecast for the first half of 2026.
• Roll out the Crown Switch vape product to other European markets, followed by the US after obtaining necessary registrations and FDA clearance.
• Continue test marketing and expanding the distribution footprint for the Vant functional inhalables in Spain and the US.
• Attend the ICR conference in Orlando in January 2026 to meet potential investors and promote the business.
• Explore bolt-on M&A opportunities, share buybacks, or dividends depending on post-merger cash position and strategic priorities.

Key Dates

Recommendation

The company presents a compelling investment case due to its strong financial performance, including profitability, significant cash flow generation, and a healthy balance sheet, which is rare for a SPAC target. Its market leadership in hookah molasses provides a stable foundation, while aggressive innovation in high-growth adjacent markets like vapes, functional inhalables, and nicotine pouches offers substantial future growth potential. The 11x EV/EBITDA valuation, while noted as high for a SPAC, appears justified by these fundamentals and growth prospects. The upcoming F-4 filing and anticipated H1 2026 listing are key catalysts.

Keywords

SPAC, Merger, Vape, Hookah, Nicotine, Quantum Chip, F-4 Filing, EBITDA, Cash Flow, Consumer Goods, Tobacco Alternatives, Innovation